Skip to main content
. 2019 Dec 13;143(1):55–68. doi: 10.1093/brain/awz379

Table 1.

Frequency of major clinical findings associated with C-terminal truncations of MN1

Phenotype Affected individuals, n (%)
Hypertelorism 19/21 (90)
Downslanting palpebral fissures 15/21 (71)
Midface hypoplasia 21/22 (95)
Cranial shape defects (plagiocephaly, brachycephaly, turricephaly, dolicocephaly, bitemporal narrowing) 16/21 (76)
Short, upturned nose 21/22 (95)
High-arched palate 15/21 (71)
Dysplastic ears 22/22 (100)
Hearing loss (conductive or sensorineural) 16/20 (80)
Speech delay 18/20 (90)
Intellectual disability 16/17 (94)
Motor delay 19/20 (95)
Feeding difficulties 12/18 (67)
Hypotonia 17/18 (94)

Note that only Individuals 1–6 and 8–23 were considered for the frequencies listed (Individual 7 was excluded because mosaicism of the MN1 mutation).